Features
Features
Lessons from anthrax
The deaths of five patients exposed to anthrax this fall put bioterrorism squarely on the map. Where does the road lead from here?
A Yale Medicine roundtable.At the 2001 annual meeting of the American Association for the Advancement of Science last February in San Francisco, an audience member asked a panel of experts on bioterrorism why the world had yet to see a major biological attack. After a moment’s pause, a response came from Stephen Morse, Ph.D., director of the Center for...
Targeting cancer by subtype
Drawing from an archive of three million tissue samples, Yale investigators are applying the latest in microarray technology to hunt down cures for tumors that resist treatment.
Read more...
Moving beyond fear
In Kenya’s lively and cosmopolitan capital, where HIV has made alarming inroads, there’s a desperate need for good prevention strategies. The right message, it seems, is one that encourages self-respect.
Read more...
Yale Medicine is the Alumni Bulletin of the Yale University School of Medicine. Read More...
